Pharmanoid is a manufacturing site specializing in the production of HPAPIs for ophthalmology. Inke, which is backed by Keensight Capital, has acquired Pharmanoid from Gentec Pharmaceutical Group.

EAST RUTHERFORD, N.J., Oct. 22, 2025 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced a $120 million investment to expand its U.S.

“Our customers, in partnership with federal and state agencies, are reshoring drug manufacturing in the U.S., the world’s largest pharmaceutical market. Local API production is vital for supply chain ...

BEIJING--(BUSINESS WIRE)-- Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”) announced today that it has entered into a definitive Asset Purchase Agreement to acquire the ...